1 – 20 of 102
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
805P Tumor-informed ctDNA detection as a predictive marker for postoperative residual disease in epithelial ovarian cancer: A feasibility study
(
- Contribution to journal › Published meeting abstract
- 2022
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
(
- Contribution to journal › Published meeting abstract
- 2021
-
Mark
Newly diagnosed and relapsed follicular lymphoma : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2021) In Annals of oncology : official journal of the European Society for Medical Oncology 32(3). p.298-308(
- Contribution to journal › Article
- 2019
-
Mark
Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities : further results from the prospective PANTHER study with focus on obese patients
2019) In Annals of oncology : official journal of the European Society for Medical Oncology 30(1). p.109-114(
- Contribution to journal › Article
-
Mark
High expression of estrogen receptor beta correlates with anti-tumorigenic and anti-proliferative inflammatory proteins in colorectal cancer patients
(
- Contribution to journal › Article
-
Mark
To investigate the role of PGD2 and its receptor signalling in colon cancer pathophysiology
(
- Contribution to journal › Article
-
Mark
15-PGDH regulated PD-1/PD-L1 immune checkpoint blockade immunotherapy in colon cancer is a TNF-α dependent phenomenon
(
- Contribution to journal › Article
-
Mark
Sperm count in Swedish clinical stage I testicular cancer patients following adjuvant treatment
2019) In Annals of oncology : official journal of the European Society for Medical Oncology 30(4). p.604-611(
- Contribution to journal › Article
- 2018
-
Mark
Characterization of male breast cancer : Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
(
- Contribution to journal › Article
-
Mark
Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers
2018) In Annals of Oncology(
- Contribution to journal › Article
-
Mark
Man against machine : diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(8). p.1836-1842(
- Contribution to journal › Article
-
Mark
Stromal progesterone receptor expression and long-term survival in patients with resected periampullary adenocarcinoma
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.262-263(
- Contribution to journal › Published meeting abstract
-
Mark
Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor-infiltrating immune cell composition
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.180-180(
- Contribution to journal › Published meeting abstract
-
Mark
Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.463-463(
- Contribution to journal › Published meeting abstract
-
Mark
Prognostic significance of lymphocyte-activation gene-3 expression in chemoradiotherapy-naïve esophageal and gastric adenocarcinoma
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.220-220(
- Contribution to journal › Published meeting abstract
-
Mark
Analytical validation of OncoMasTR, a multigene test for predicting risk of distant recurrence in hormone receptor-positive early stage breast cancer
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.65-65(
- Contribution to journal › Published meeting abstract
-
Mark
A phase III study of INCB054828 as adjuvant therapy in patients (pts) with high-risk urothelial carcinoma (UC) harboring fibroblast growth factor receptor 3 (FGFR3) genomic alterations
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.328-328(
- Contribution to journal › Article
-
Mark
Intermediate prognosis in metastatic germ cell tumors (IPGCT) : Outcome and prognostic stratification
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29. p.325-325(
- Contribution to journal › Article
- 2016
-
Mark
Cancer mortality in cohorts of workers in the European rubber manufacturing industry first employed since 1975.
(
- Contribution to journal › Article
-
Mark
A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial
(
- Contribution to journal › Article